Open AccessCharacteristic of CD4+CD25+ T Cells in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate with Different BCR-ABL Transcripts Levels Response
Author(s) -
Fadhil Sabir,
Wallaa Abedlhaq Mahmood,
Ali Alwatar,
Bassam Francis Matti
Publication year - 2021
Publication title -
medico-legal update/medico-legal update
Language(s) - English
Resource type - Journals
eISSN - 0974-1283
pISSN - 0971-720X
DOI - 10.37506/mlu.v21i1.2438
Subject(s) - il 2 receptor , myeloid leukemia , medicine , flow cytometry , imatinib mesylate , imatinib , immunology , immune system , breakpoint cluster region , cancer research , oncology , t cell , receptor